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Mammalian prolactin stimulates growth and inhibits metamorphosis of larvae 
of several species of amphibians. Mammalian somatotropin has little or no effect 
upon larval growth or metamorphosis unless used in high concentrations. The evi- 
dence behind these statements and some of the implications are critically evaluated. 
Growth of postmetamorphic amphibians is stimulated by somatotropin but not by 
prolactin. The possible biological significance of this apparent transition from pro- 
lactin to somatotropin regulation of growth in the pre- and postmetamorphic stages of 
development is discussed in terms of possible mechanisms involved in the tran- 
sition, and in terms of the adaptive significance of the change. 
The best current model of hormonal species of amphibians takes place after 
regulation of amphibian development pro- metamorphosis, comparison of the endo- 
poses a double system of control consisting crine regulation of growth during this phase 
of thyroxine, which stimulates metamor- of the life cycle with the larval phase is of 
phosis and thus brings larval growth to a particular interest and will be discussed 
halt, and prolactin, which has the combined in the latter part of the paper. Most of the 
effects of stimulating larval growth and information which will be discussed is 
inhibiting metamorphosis (Etkin and Gona, based on work with relatively highly puri- 
1967; Bern, Nicoll, and Strohman, 1967; fied mamrnalian hormones. There is fortu- 
Etkin, I96Sj. The secretion of these two nately some support for this work from a 
hormones is presumed to follow a recip- few studies of the effects of hypophy- 
rocal pattern of rising thyroxine and de- sectomy and implants or homogenates of 
clining prolactin as metamorphosis pro- amphibian pituitary on growth and meta- 
gresses, the pattern being determined by morphosis. 
developmental changes in the thyrotropin 
releasing and prolactin inhibiting functions LARVAL GR.0 WTH 
of the hypothalamus. We will review some The pituitary gland has been known to 
of the evidence for the role of prolactin in play a role in the control of growth. of 
amphibian growth and metamorphosis. amphibian larvae since the first quarter 
Since a major part of the growth of most of this century when several investigators 
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showed that growth is retarded by hy- 
pophysectomy and stimulated by implants 
or extracts of adult amphibian or bovine 
pituitary glands (cf. Smith, 1920; Allen, 
1929; Willier, 1955). These observations 
have been confirmed in recent years (Etkin 
and Lehrer, 1960; Enemar and Mecklen- 
burg, 1962; Hanoka, 1967; Oliver0 et al., 
1968). There was no indication in the 
earlier studies as to the nature of the 
growth promoting factor(s), or even 
whether a specific growth hormone was 
involved as opposed to growth effects 
which were secondary to effects of the 
pituitary upon adrenal and thyroid func- 
tion. Although we now know that mam- 
malian prolactin is a strong stimulant to 
tadpole growth (see below), the question 
of the nature of the growth promotmg ac- 
tion of the intrinsic pituitary gland still 
had not been adequately resolved. The 
legitimacy of some reservation on this point 
is underscored by the recent report of Just 
and Kollros (1968) that immersion of hy- 
pophysectomixed tadpoles in very dilute 
solutions of thyroxine (0.08 pg/liter) is 
sufficient to restore growth to normal rates. 
The first suggestion that prolactin or a 
prolactin-like hormone might be the specific 
growth hormone secreted by tadpole pitui- 
taries was made by Etkin and Lehrer in 
1960. They showed that tadpoles bearing 
ectopic pituitary autografts grow at faster 
rates and to larger ultimate size than intact 
animals, and suggested that the ectopic 
glands were secreting above normal 
amounts of some growth promoting factor. 
On the basis of analogy with the mam- 
malian hypothalamo-hypophysial system, 
in which prolactin secretion is under in- 
hibitory control, they proposed that the 
tadpole growth factor might be prolactin. 
The observational basis for this suggestion 
has been confirmed, both with ectopic 
grafts (Brown, unpublished), and by hy- 
pothalectomy which also leaves the pitui- 
tary in a deafferented state (Hanoka, 1966; 
Remy and Bounhiol, 1966; Guardabassi 
et al., 1961). 
As a result of the work of Etkin and 
Lehrer, several groups of investigators have 
studied the effects of prolactin upon the 
growth of amphibian larvae (Berman et 
al., 1964; Remy and Bounhiol, 1965, 1966; 
Bern et al., 1967; Etkin and Gona, 1967; 
Gona, 1967; Enemar et al., 1968; Guarda- 
bassi et al., 1968; Brown and Frye, 1969a; 
Medda and Frieden, 1970; Snyder, 1970). 
This work has shown in larvae of several 
species of amphibians, including Rana 
pipiens, R. grilio, R. catesbeiana, R. tem- 
poraria, Alytes obstretricans, and Bufo 
bufo, that mammalian prolactin is a strong 
stimulator of growth. The growth response 
to prolactin injections is prompt, usually 
being noticeable within 34 days after 
treatment is begun, and occurs after 
reasonably small doses of the hormone. In 
R. pipiens and R. catesbeiana doses in the 
order of l-50 pg/animal/day are effective 
in promoting growth, a dose which is 
roughly equivalent to 0.1-5 mg/kg, or com- 
parable to the effective levels of somatot- 
ropin ordinarily used in mammals. On the 
basis of data published to date it is not 
possible to characterize the dose response 
curve satisfactorily. In our hands (Brown 
and Frye, 1969a) there is no clear indica- 
tion of a linear dose-response relationship 
over the range from 0.569 ,ug/animal. 
Moreover, the minimum effective dose (be- 
tween 0.5-l pg/animal/day) gives an es- 
sentially maximum response. A similar lack 
of linear dose-response relationship has 
been reported with respect to the effect of 
prolactin on urea excretion (Medda and 
Frieden, 1970). In part this phenomenon 
may be due to the considerable variability 
of the response of individual tadpoles. 
Nonetheless, properly designed dose-re- 
sponse assays using more closely spaced 
doses of hormone need to be done in order 
to determine whether the response is graded 
in some geometric or arithmetic relation- 
ship, or whether we are dealing with an 
all or none response, possibly suggestive 
of a threshold phenomenon. 
The growth response to prolactin has 
generally been measured in terms of an in- 
crease in wet and dry weight, total length, 
and tail width. In two recent studies pro- 
lnctin has also been shown to reduce total 
nitrogen excretion (Medda and Frieden, 
1971), an apparently anabolic effect, and 
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enhance incorporation of labeled amino 
acid into protein (Snyder, 1970; Yoshieato 
and Yasumasu, 1970). In the study by 
Snyder prolactin significantly enhanced the 
incorporation of amino acid into protein 
in two experiments out of three (Table 1). 
In view of the considerable magnitude of 
the growth response when measured in 
terms of length or weight increment the 
modest increment in amino acid incorpora- 
tion in two experiments, and the lack of a 
significant effect in the third is rather sur- 
prising. This could suggest that the major 
effect of prolactin is to decrease protein 
cat.abolism rather than to stimulate protein 
synthesis, or it could reflect dilution of the 
labeled precursor in a large, rapidly turn- 
ing over amino acid pool with the result 
that the apparent rate of protein synthesis 
is lower than the real rate. The effect of 
prolactin upon protein synthesis occurred 
without any change in amino acid pool 
size, and hence is presumably not an effect 
upon amino acid uptake, but a more direct 
stimulation of the biosynthetic process. 
More detailed studies of the biochemical 
basis of the growth effect of prolactin are 
badly needed, not only for the sake of es- 
tablishing the mechanism of action, but. 
also as a possible basis for understanding 
the interrelationships of prolactin and thy- 
roxine in larval growth and metamorphosis 
(see below) . 
An aspect of the growth promoting ac- 
t,ion of prolactin which has not been sys- 
tematically explored is whether the effect 
is generalized or whether different tissues 
respond differentially. There are some in- 
dications, however. For example, there is 
a common emphasis in the literature which 
suggests t’hat the growth of the tail, par- 
AND METAMORPHOSIS 231 
titularly the fin, is especially sensitive 
(Yoshizato and Yasumasu, 1970). (This 
calls to mind the numerous other effects 
of prolactin upon the integument and its 
derivatives, cf. Bern and Nieoll 1968.) 
Hind-leg growth, on the other ha&l is not 
stimulated, and may in fact be inhibited, 
perhaps due t’o an antagonism of the ac- 
tion of thyroxine (see below) I 
The growth promot’ing effect of prolaetin 
in amphibian larvae may not be entirely 
specific. Somatotropin preparations of 
mammalian origin have been shown to 
have appreciable growth promoting ac- 
t,ivity, in some instances as great as or 
greater than prolactin (Remy and BOW- 
hiol, 1966; Enemar et al., 1968). However, 
in our hands as well as several other in- 
vestigators’ (Etkin and Gona, 3.967; Bern 
ei al., 1967; Brown and Frye, 1969a, Sny- 
d.er, 1970) the growth st’imulating activi-ty 
of somatotropin is much less than that of 
prolactin, and can probably be accounted 
for by the levels of prolactin contamina- 
tion which most, somatotropin preparations 
have (cf. Brown and Frye, 1969a ; 
and Brown, 1971). Nonetheless, it Is pos- 
sible that somatotropin does possess in- 
trinsic growth promoting activity in am- 
phibian larvae. The relative potency of 
prolactin and somatotropin in inducing 
growth may vary with the species in which 
they are tested; with variations in test cir- 
cumstances such as the time of hormone 
administration relative to diurnal rhythms 
(cf. Meier, 1969) ; or with developmental 
stage and state of thyroid or ot,her en- 
docrine activit,y of the test animals. Such 
factors could readily affect the apparent 
relative potencies of prolactin and so- 
matotropin if they promote growth by 
TABLE 1 
INCORPOR.ZTION OF W-AMINO ACID INTO TADPOLE TML MUSCLE AFTER PROLACTIK 
AND GROWTH HORMONE TREATMENTS 
Expt. 1 l-zxpt. 3 Expt. 4 
- ~__-- 
Control 1287 + 150 2139 & 178 1767 + 13.5 
Prolactin 1870 + 208* 2147 * 148 2245 k 154b 
Somatotropin 1312 rt 174 1830 ir 153 1810 + 161 
a Taken from Snyder (1970). Values are dpm/mg protein X weight of tadpole. 
b Indicates a significant difference with a p of 0.05. 
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different mechanisms. For example, Brown 
(1968) has shown that thyroidectomy en- 
hances the sensitivity of tadpoles to soma- 
totropin Z-10 times that of intact controls. 
Under these conditions the effect of soma- 
totropin can no longer be accounted for in 
terms of prolactin contamination, unless 
of course thyroidectomy also enhances 
sensitivity to prolactin. As will be dis- 
cussed below prolactin acts, in part, by 
inhibiting metamorphosis, an effect which 
somatotropin does not have. Since most 
somatotropin preparations are contam- 
inated with thyrotropin they tend to ac- 
celerate metamorphosis. This effect could 
obliterate any growth promoting action of 
somatotropin in tadpoles. It is obviously 
premature to rule out somatotropin as an 
important growth factor in larval am- 
phibians. In fact, at the present state of 
knowledge, we cannot deny the possibility 
that the growth effects of prolactin prep- 
arations are due to the combined anti- 
metamorphic effect of prolactin plus a 
specific anabolic effect of the somatotropin 
which contaminates these preparations! 
METAMORPHOSIS 
We have already alluded to the fact that, 
in addition to stimulating growth, mam- 
malian prolactin preparations also inhibit 
metamorphosis (Nicoll et al., 1965 ; Etkin 
and Gona, 1967; Gona, 1967, 1968; Bern 
et al., 1967; Campantico et al., 1968; Derby 
and Etkin, 1968; Brown and Frye, 1969a; 
Etkin, Derby and Gona, 1969; Derby, 
1970; Gona and Etkin, 1970; Medda and 
Frieden, 1970). The criteria by which this 
effect has been shown include prevention 
of tail reabsorption and other events of 
metamorphic climax; arrest of the progres- 
sion of normal developmental stages, and 
arrest of hind-leg growth, a thyroxine de- 
pendent trait which reflects metamorphic 
progression. Recently prolactin has also 
been shown to suppress urea excretion by 
normal or triiodothyronine treated tadpoles 
(Medda and Frieden, 1970). Since a normal 
metamorphic rise in urea excretion is in- 
duced by thyroid hormones (cf. Frieden, 
1968) this effect can be interpreted as a re- 
pression of the metamorphic transition from 
ammoniotelism to ureotelism. However, this 
interpretation must be viewed cautiously 
since the reduction in urea excretion may 
reflect an anabolic action of prolactin, 
causing general nitrogen retention, rather 
than a specific effect on development of the 
urea cycle. This reservation seems to be 
supported by the recent report of Medda 
and Frieden (1971) that prolactin also re- 
duces ammonia and total nitrogen excretion 
in tadpoles, and by the observations of 
Blatt et al. (1969) and Guardabassi et al. 
(1970) that, prolactin does not suppress, and 
may actually stimulate, carbamyl phos- 
phate synthetase and arginase, key en- 
zymes of the urea cycle. Rough comparison 
of the data in the two papers of Frieden and 
Medda suggests that in fact urea excretion 
is not repressed to a greater degree than 
ammonia. Data are needed on the precise 
ratios of ammonia to urea excretion before 
a good case can be made for inhibition of 
induction of the urea cycle as opposed to 
a positive anabolic effect as the basis for 
this phenomenon. 
According to most investigators anti- 
metamorphic effects are possessed only by 
prolactin, and not by mammalian soma- 
totropin. In fact, somatotropin has been 
reported several times to accelerate meta- 
morphosis (Bounhiol et aZ., 1959; Nicoll 
et al., 1965; Etkin and Gona, 1967; Just 
and Kollros, 1968; Brown and Frye, 
1969a). This may be a consequence of 
thyrotropin contamination of most soma- 
totropin preparations rather than an effect 
of somatotropin itself. This view has been 
tentatively confirmed by the lack of a 
metamorphosis accelerating effect of a 
porcine somatotropin preparation which 
contained very low thyrotropin contamina- 
tion (Brown, 1968). It is likely that the 
prolactin preparations which have been 
used in most experiments also contain 
significant amounts of thyrotropin, but its 
activity is apparently obscured by the 
antimetamorphic effect of prolactin. Pro- 
lactin has been shown to overcome the 
metamorphosis stimulating effect of rather 
large doses of thyrotropin (Gona, 1967). 
Therefore it is clear that the action of 
somatotropin differs from the action of 
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prolactin insofar as any effect on metamor- 
phosis is concerned. It may be significant 
that somatotropin suppresses urea excre- 
tion almost as effectively as prolactin 
(Medda and Frieden), a phenomenon 
which could suggest that the anabolic ac- 
tions of preparations of the two hormones 
are equivalent and that differences relate 
to their antimetamorphic activities. 
Ect,opie pituitary grafts also inhibit 
metamorphosis, whether tested in the whole 
animal (Etkin et al., 1969) or on pieces of 
isolated tail fin in vitro (Derby and Etkin, 
1968). Moreover, the metamorphosis in- 
hibiting activity of grafts of larval pitui- 
tary declines as the donor progresses from 
prometamorphosis to metamorphic climax, 
and is undetectable in the pituitary of the 
postmetamorphic froglet (Derby, 1970). 
This pattern of change corresponds to the 
theoretical model for prolactin secretion 
during metamorphosis mentioned in the 
introduction. Such informat’ion strongly 
augments the results obtained with mam- 
malian prolactin in indicating that the 
antimetamorphic effect is a normal physio- 
logical function of a larval pituitary hor- 
mone, i.e., prolactin or a prolactin-like hor- 
mone. A point worthy of note in this 
connection is that the pituitary implants 
and extracts used in the early work of 
Smith and Allen (cf. Allen, 1929) accel- 
erated growth but did not precipitate 
metamorphosis. Since, as noted above, even 
relatively highly purified preparations of 
somatotropin (as well as other pituitary 
hormones) eont,ain appreciable levels of 
thyrotropin contamination, these early 
preparations must surely have contained 
sufficient amounts of thyrotropin to cause 
a precipitous onset of metamorphosis. The 
fact that they did not indicates, in retro- 
spect, that a metamorphosis inhibiting 
agent, presumably prolactin, must have 
also been present in those preparations. 
Two possible mechanisms for the anti- 
metamorphic action of prolactin have been 
examined: (1) a central antithyroid effect, 
the consequence of which is to suppress 
thvroid hormone secretion; and (2) a pe- 
ripheral effect which interferes with or 
counteracts the metamorphic action of thy- 
roxine on the target tissues. The first pos- 
sibility has been tested by means of studies 
of thyroid histology and radioiodine me- 
tabolism, with conflicting results by dif- 
ferent investigators. On the one hand, Gona 
(1967, 1968) finds that proiactin blocks the 
stimulation of metamorphosis caused by 
exogenous thyrotropin, but not that, caused 
by exogenous thyroxine. IIe therefore be- 
lieves that prolactin blocks at the level 
of the thyroid the synthesis or secretion 
of thyroxine, and supports this conclusion 
by showing that iodine uptake by thyroids 
of prometamorphic tadpoles is depressed 
by prolactin. However, he was unable to 
show any effect of prolactin upon the T/S 
I, or the ratios of various iodine 
containing components (iodide, mono-aild 
diiodotyrosine, triiodothyronine and thy- 
roxine) of thyroid hydrolysates of climax 
tadpoles, even th~gil completion of meta- 
morphosis wa,s inhibited. Ne does shop 
that PI31 was reduced by prolactin in 
prometamorphic animals. However, shee 
the determinations were of necessity based 
on pooled blood samples and not subjected 
to statistical comparison, the data are not 
completely convincing. 
On the other hand Campantieo et al. 
(1968) find that the effect of prolactin upoc 
iodine uptake varies with the develop- 
mental stage of the tadpoles, inhibiting 
uptake in younger stages and stimulating 
in older ones. They therefore believe that 
prolactin stimulates the thyroid as the 
stage of met’amorphosis approaches, and 
support this conciusion indirectly by show- 
ing that arginase activity, a supposedly 
thyroxine dependent trait, is induced 
precociously in prolactin treated t~adnoles 
(Guardabassi et al., 1970). However, even 
though arginase is normally induced by 
thyroid hormone. it, does not seem to be 
established that this is a totally specific 
effect’, and it is quite possible that prolactin 
itself, or other changes associated with 
prolactin treatment, are responsible for the 
activation of arginase. This controversy as 
to whether prolactin is inhibitory or stim- 
ulatorv to the thvroid has been extended 
to no&metamorphic newts (Grant and 
Cooper, 1965; Vellano et ai., 1967; Gona 
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et al., 1970). We are forced to conclude 
that the question of a central antithyroid 
effect of prolactin in amphibian larvae re- 
quires further investigation with careful 
experimental design susceptible to statis- 
tical analysis before it can be resolved 
one way or the other. 
The evidence for a peripheral effect of 
prolactin in blocking metamorphosis is 
somewhat more convincing, though not 
completely without conflicting points. Bern 
et al. (1967) and Medda and Frieden 
(1970) have shown that prolactin inhibits 
the induction of metamorphosis caused by 
immersion of tadpoles in, or injection with, 
solutions of exogenous thyroxine. On the 
other hand, Gona (1967) and Brown and 
Frye (1969a) were not able to show any 
effect of prolactin in blocking metamor- 
phosis induced by immersion of tadpoles 
in concentrations of thyroxine ranging, in 
the latter study, from 4-100 pg/liter. The 
reasons for the difference in the results is 
not known, but it is possible that the an- 
tagonistic effect is achieved only at a 
specific balance in the concentrations of 
the two hormones which the latter workers 
were not fortunate enough to produce. It 
is also possible that the response to com- 
binations of thyroid hormone and prolactin 
varies with the stage of development and 
with levels of endogenous hormones in the 
test animals. Ectopic pituitary grafts in 
tadpoles whose own pituitary is intact also 
retard spontaneous metamorphosis. A di- 
rect peripheral effect is indicated by the 
fact that the inhibition of resorption of tail 
tissue in the immediate vicinity of the 
grafts is inhibited more than in more dis- 
tant areas (Etkin, Derby, and Gona, 1969). 
Similarly, Etkin and Derby (1968) and 
Derby (1970) have shown that larval pi- 
tuitary grafts placed in isolated disks of 
tail fin in vitro prevent the resorption 
which is induced by thyroxine. Prolactin, 
and to some extent somatotropin, also pre- 
vented resorption, although the purified 
hormones were seemingly less effective than 
pituitary grafts. The relative impotency 
of the mammalian hormones could be due 
to inefficient uptake or retention of the 
hormone under in vitro conditions, but it 
could also suggest that the factor produced 
by the tadpole pituitary is not identical 
to mammalian prolactin. 
INTERRBLATIONSHIP OF HORMONAL 
EFFECTS IN GROWTH AND 
METAMORPHOSlS 
Since prolactin both promotes larval 
growth and inhibits metamorphosis, the 
question arises whether there is a direct 
connection between these two effects. The 
level of thyroid hormone it.self influences 
growth. Low levels enhance growth of hy- 
pophysectomised larvae (Just and Kollros, 
1968), and conversely, the growth of other- 
wise intact tadpoles is accelerated by sup- 
pression of thyroid function (Steinmetz, 
1952, 1954; Clerici and Gabanino, 1967). 
Thus, it is entirely possible that the growth 
promoting action of prolactin is entirely 
due to its antithyroid effects rather than 
to a more direct anabolic action. This pos- 
sibility is enhanced by a number of ad- 
ditional considerations which emphasize 
the existence of a connection between the 
growth and the metamorphosis inhibiting 
actions of prolactin: (1) The concurrence 
of the growth and metamorphic effects can, 
of course, be most simply explained if they 
result from a common primary effect; (2) 
The magnitude of stimulation of incorpo- 
ration of labeled amino acid into protein 
of tail muscle under the influence of pro- 
la&in is less than might be expected from 
the magnitude of the growth effect (Sny- 
der, 1970). This could be explained if pro- 
lactin were antagonizing a thyroxine-de- 
pendent catabolic process rather than 
directly stimulating protein synthesis; 
and (3) Hypophysectomized larvae grow 
normally until about mid-larval life when 
growth is arrested (cf. Etkin and Lehrer, 
1961). The thyroxine dependent phase of 
larval development begins at approxi- 
mately this same time (cf. Steinmetz, 1952, 
1954; Hanaoka, 1967). 
The possibility that the growth effect of 
prolactin is solely due to its antithyroid 
effects has been tested by Brown and Frye 
(1969a) who showed that prolactin stim- 
ulates growth of tadpoles treated with 
propylthiouracil, or thyroidectomiaed, more 
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than thyroid depression alone stimulates 
growth. In addition, Brown (1968) has 
shown in one experiment that in premeta- 
morphic tadpoles (approximately stage IX 
of the Taylor and Kollros series ; prior to 
the thyroxine dependent stage of meta- 
morphosis) prolact,in stimulates growth but 
does not affect the progression of meta- 
morphic stages. In further support of the 
separateness of the growth and meta- 
morphic effects, we have found that there 
is an apparent difference in the minimum 
dose of prolactin required to influence the 
two phenomena. Five micrograms per day 
were required to noticeably retard meta- 
morphosis, whereas the minimum effective 
growth stimulating dose was between 0.5 
and 1 pg/day.l These results seem to show 
that prolactin induced growth has two 
components: that caused by suppression of 
the production or action of thyroid hor- 
mone, and that caused by a direct anabolic 
effect of prolactin on the peripheral tissues. 
This conclusion should not be accepted too 
easily, however, and needs to be confirmed 
in at least two ways: (1) by demonstrating 
that the ability to produce both effects is 
possessed by completely pure prolactin, 
i.e., that the anabolic effect is not due to 
somatotropin contamination, for example; 
(2) by comparative study of the processes 
which are affected by prolactin, somatot- 
ropin, and thyroid hormone at the molec- 
ular level. Finally, the role of the thyroid 
itself in growth regulation needs to be more 
fully characterized. As has already been 
noted thyroxine stimulates net growth of 
hypophysectomized animals when admin- 
istered at low doses, and conversely, the 
*Neither of the last two arguments is of itself 
very strong. The first, based on the observation 
that young developmental stages may not be 
arrested in metamorphosis by prolactin is weak 
because the lack of an overt effect on metamor- 
phosis as assessed by morphological criteria does 
not mean that effects on molecular processes 
common to both growth and metamorphosis are 
not occurring. The second, based on a higher 
dose requirement for metamorphosis inhibition 
than for growth stimulation is weak because two 
different endpoints used to assay the same effect 
may differ in sensitivity. 
growth of otherwise intact tadpoles is ac- 
celerated by thyroidectomy and inhibited 
by thyroxine closes great enough to cause 
metamorphosis. It is thus to be expected 
that the response of an animal to l)rola,ctin 
will be variously influenced by differem 
levels of thyroid fur&ion. The converse is 
equally true. 
GROWTH AFTER METIZMOHPHOSX8 
There have been very few studies of the 
role of the pituitary in regulating growth 
of postmetamorphic amphibians. Apple et 
al. (1966) showed that hypophpsectomy 
accelerates loss of lean weight of fasted 
toa,ds. This effect, though not measured 
specifically in terms of growth, presumably 
reflects an anabolic action of somatotropin 
or other pit’uitary hormones comparable 
to that seen in mammals (cf. Snipes, PZ$) ~ 
Subsequently, Brown and Frye (1969b) 
showed that hypophysectomy retards or 
arrests growth of juvenile frogs when meas- 
ured in terms of weight or length gain. 
These studies suggest that the postmeta- 
morphic amphibian pituitary may have a 
somatotropic function similar to that seen 
in mammals, but work with hormone re- 
placement is needed to establish this. To 
date, such work has been restricted to the 
administration of purified mammalian pro- 
lactin and somatotropin. We have shown 
that juvenile R. pipiens grow in weight and 
length in response to 5-10 big (appmxi- 
mately 1-2 pg/g) per day but do not grow 
in response to doses of prolactin as high 
as 50 pug/day over an 11-week period. 
result has been confirmed by Snyder (I 
who also showed that somatotropin stim- 
ulates incorporation of labeled amino acid 
into protein in muscle and gut (but not 
liver) whereas prolactin does not. Zipser 
et al. (1969) have reported similar results 
with two species of toads, BuJo WLW~~US 
and B. borealis. They were able to stim- 
ulate growth in t,hese species with as iitt‘le 
as 0.3 fig/day of somatotropin ialoproxi- 
mately 0.1-0.03 pg/g) but could obtain 
growth in response to prolaetin only when 
the dose was great, enough (5%-100 ,~gjdayj 
for the effect to be accounted for by con- 
taminating somatotropin. Toacie proved to 
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be much more sensitive to somatotropin 
than frogs, both in terms of minimal effec- 
tive dose and in terms of the rate of growth. 
Finally, Brown and Brown (1971) have 
recently shown that somatotropin is more 
effective in stimulating growth of the adult 
newt, Notophthalnzus viridescens, than 
prolactin, although the difference in the re- 
sponse to these two hormones is not as 
great as in the anurans. 
SPECULATIONS ABOUT THE SIGNIFI- 
CANCE OF THE DIFFERENCES IN 
PRE- AND POSTMETAMORPHIC 
GROWTH RESPONSES 
The apparent inversion in relative sen- 
sitivity of growth processes to somatotropin 
and prolactin at metamorphosis requires 
explanation, both in terms of the mecha- 
nism of the change, and in terms of the 
adaptive significance of the phenomenon. 
There is no information available about 
the mechanistic basis for the difference in 
sensitivity to prolactin and somatotropin 
before and after metamorphosis. However, 
several hypothetical considerations may 
help to focus the problem. First, on the 
basis of responses to mammalian hormones, 
we should expect to find a comparable in- 
version in the relative amounts of prolactin 
and somatotropin (or equivalent related 
substances) secreted by the pituitary in 
larval and postmetamorphic stages of de- 
velopment. Both prolactin and somato- 
tropic activities are detectable in pituit,aries 
of adult amphibians (cf. Solomon and 
Greep, 1959; Nicoll et al., 1966) but there 
is no basis for evaluating relative activity 
at different stages in the life cycle. Derby’s 
work (1970) showing that metamorphosis 
inhibiting activity of larval pituitaries de- 
clines during metamorphosis to become un- 
detectable in the juvenile frog is suggestive 
of a decline in prolactin, but needs to be 
confirmed by the use of standard prolactin 
and somatotropin assays. Second, changes 
in the sensitivity to prolactin and growth 
hormone during development could reflect 
changes in the activity of other synergistic 
or antagonistic hormones rather than fun- 
damental changes in the response .to pxo- 
la&in or somatotropin at the molecular 
level. The possible complex interactions of 
the thyroid and pituitary hormones in 
larval growth have already been mentioned 
and may extend to postmetamorphic de- 
velopment. Third, the fundamental molec- 
ular basis of the response to prolactin and 
somatotropin must be known before the 
meaning of changes in sensitivity based 
.on overt growth can be evaluated. If pro- 
lactin and somatotropin promote growth 
in totally different ways, for example, if 
prolactin inhibits catabolic processes and 
somatotropin stimulates anabolic processes, 
then differences in the kinetics of larval 
and subadult enzymes controlling each of 
these processes could lead to apparent 
metamorphic changes in the sensitivities of 
the processes to the hormones controlling 
them even though the primary molecular 
responses to the hormones had not been 
altered. On the other hand, if both hor- 
mones promote growth through the same 
anabolic pathways, then differences in sen- 
sitivity at different stages of development 
imply changes in the primary events of 
hormone action. Finally, it is possible that 
prolactin and somatotropin are acting upon 
different cells or tissues which comprise 
different proportions of the organism be- 
fore and after metamorphosis. In this case, 
changing patterns of response to prolactin 
and somatotropin would not involve cel- 
lular differentiation per se, but would re- 
flect a decline in the numbers of prolactin 
sensitive cells, and a rise in numbers of 
growth hormone sensitive cells comprising 
the hormone sensitive tissues. 
Perhaps the most intriguing and difficult 
question which arises from the work which 
has been described is that of the adaptive 
significance of the metamorphic transition 
from prolactin to somatotropin control of 
growth, Assuming that the implication of 
the work with mammalian hormones is cor- 
rect-namely that the ability to secrete 
and respond to both prolactin and soma- 
totropin is within the genetic canabilities 
of an amphibian-what considerations 
have favored the use of nrolactin during 
the larval phase of growth and somatot- 
ropin during postmetamorphic growth? 
St.udies of the molecular basis of the effects 
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of the two hormones, by revealing exactly 
what each is doing, may provide some in- 
sight into this question. But the total pic- 
ture can become apparent only by con- 
sideration of the complete spectrum of 
effects of each of the hormones and the 
relationships of these effects to growth on 
the one hand and to special features of 
larval or postmetamorphic life on the 
other. For example, it is well known that 
the growth promoting effects of somatot- 
ropin in mammals are accompanied by 
numerous interrelated effects upon the 
metabolism of carbohydrate, fat and pro- 
tein, which are conducive to the shunting 
of as much of the available foodstuffs as 
possible into lean growth while simul- 
taneously sustaining carbohydrate reserves 
necessary for other metabolic requirements. 
It seems apparent that a growth-regulating 
hormone with these complementary effects 
would, in the course of evolution, have 
selective advantage over a hormone? with 
effects less encompassing of the relevant 
features of the biology of the organism. 
Thus, it is of interest to know whether 
there are aspects of the composite actions 
of prolactin and somatotropin which could 
enhance their value as growth regulators 
in t.he larval and the postmetamorphic 
stages of development, respectively. There 
appear to be only two relevant sets of 
observations bearing on this problem: 
(1) As already discussed, prolactin both 
inhibits metamorphosis and stimulates 
growth during the larva1 phase of develop- 
ment. It seems apparent that prolactin, by 
combining these two properties, has supe- 
riority over somatotropin as a mechanism 
for fully exploiting the larval phase of de- 
velopment, and (2) The effects of soma- 
totropin and prolactin upon the composi- 
tion of the body with respect to major 
foodstuffs appear to be different in the two 
stages of development. In the larval stage 
neither prolact,in nor somatotropin have 
any major effects on the relative content of 
‘Obviously the hormone as a chemical entity 
of itself has no adaptive or evolutionary signifi- 
cance outside of the context of the target which 
it affects, and we are in reality speaking here of 
the hormone-target system. 
any major biochemical constituent. But in 
the juvenile frog (Snyder and Frye, 1971) 
or toad (Zipser et al., 1969) somatotropin, 
in additon to stimulating protein synthesis 
and growth, causes a pronounced 1: 
tion in lipid and glycogen stores 
versely, hypophysectomy elevates lipid 
and glycogen content relative to controls 
(Snyder and Frye, 1971; Epple eC ab., 
1966). Prolactin has much less effect on 
biochemical composition, although it tends 
to cause changes in the same direction as 
somatotropin when it has any effect at al!. 
Thus, as in mammals, somatotropin has 
interrelated effects in the juvenile anuran 
which tend to shunt a large portion o 
caloric intake or reserve into gr 
rather than energy storage depots.” 
possible that. such effects on the metabolic 
balance in the use of foodstuffs would be of 
no value in the continuous feeding, herbi- 
vorous tadpole, or even unadaptive by 
virtue of antagonizing the storage of energy 
reserves which are needed in metamor- 
phosis. The full arguments behind these 
ideas are too complex and lengthy to 
present here, and the reader is asked CO 
consult Snyder and Frye (1971) for further 
details. 
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DISCUSSION 
BAGNARA: In consideration of growth in larvae one seldom considers the intrinsic 
growth rate of tadpoles. Hypophysectomized tadpoles continue to grow long after 
their siblings have metamorphosed. Some become as much as twice as large as their 
siblings when metamorphosed. There also seems to be differential growth with 
soft tissues growing more than skeletal elements. 
FRYE: One implication of Dr. Bagnara’s comment is that there may be dif- 
ferential responses of different tissues to hormones which stimulate growth. As 
stated in the text, there have been very few studies of this, although it is quite 
clear that the growth of the tail or tail fin responds more intensely to prolactin 
than other tissues. 
HANKE: In regard to the comment by Dr. Bagnara, hypophysectomized tadpoles 
of Xenopus have large fat bodies. After treatment of these larvae with ACTH or 
corticosteroids the fat body size and the amount of triglycerides in the body are 
reduced (Gunesch, our laboratory). 
BAGNARA: What growth criteria do you use in larvae and adults? I think that 
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water uptake may be an important phenomenon in comparing growth effects in 
larvae and adults. This is especially important in view of the implications of pro- 
lactin in water balance. 
FRYE: Water uptake may be an important factor, especially in view of the well 
known osmoregulatory effects of prolactin in fish. However, the criteria used in- 
clude, in addition to wet weight, increases in linear dimensions, dry weight, and 
incorporation of C-14 labeled amino acids into protein. All of these criteria seem 
to indicate that we are dealing with real growth and not merely water uptake. 
LIGHT: In regard to the comment by Dr. Bagnara, criteria for growth in tadpoles 
are extremely important and may account for apparent discrepancies. For example, 
in Rana catesbeiana, STH stimulates trunk growth but. not tail growth, whereas 
proIactin has the reverse effect. Failure to measure trunk length aeeonnts for the 
earlier conclusion that STH is not somatropic in this tadpole. 
PESETSKY: If I understood you correctly, Dr. Frye, you reported that your 
thyroidectomized tadpoles grew at a rate greater than that of normal larvae. This 
contrasts with my experience with Rana @piens tadpoles thyroidectomized in em- 
bryonic stages. Although these larvae, in a year or so, grew to “giant” size, therr 
rate of growth seemed no greater than that of young normal larvae, and, indeed, 
the rate of growth may be a bit slower than normal. 
FRYE: In our work as well as some others, growth rate of tadpoles thyroidec- 
tomized in midlarval development (Taylor-Kollros Stage XII-XV) was accelerated 
relative to controls. However, this is very probably due to the fact that during the 
experimental period the controls reached the growth plateau which precedes overt 
metamorphosis rather than to a positive acceleration of the growth of thyroidec- 
tomized animals. You are correct in pointing out this distinction 
PESETSKI-: You have demonstrated that in larvae, thyroidectomy results in an 
increase in sensitivity to STH. Would you care to specu1at.e on the possibility that 
the “inversion” of response to STH after metamorphosis might be a result in the 
postmetamorphic drop in thyroid activity. Thus, the adult, like the thyroidectomizcd 
larvae, would display a heightened response to growth hormone. 
FRYE: This is a possibility that has occurred to us but has not yet been tested. 
Mowever, by analogy with mammals one mouid expect some thyroxin to be required 
to synergize with somatotropin to get the maximum growth response to the latter 
hormone. 
Lrmr: Regarding Dr. Pesetsky’s comment, administration of TSH to postmeta- 
morphic toads does not influence the activity of exogenous STH. 
LICHT: Conclusions regarding the relative importance of STH versus prolactin 
on growth of postmetamcrphie Anura must .be made cautiously. Dr. j?&oll and I 
have recently found that STH from al1 tetrapods stimulates growth in the toad 
(Bufo boreas), and many prolactins do not. However, some prolactins (e.g., from 
ovine, bovine, turtle, and possibly toad) are also highly potent somatotropins in 
the postmetamorphic toad. 
KALTENBACX: Prolaetin is known to stimulate the water drive in the red eft. Does 
it also stimulate growth in this animal? 
BROWN: Waterman (1965) has reported increase in body weight in red efts in 
response to prolactin. We have also found that both prolactin and GH increase 
growth rate in aquatic adult-stage Notopthalmus viridescens, with GH being more 
effective. 
XALTENBACE : Does prolactin have any effect on gonad development of the 
tadpole? 
FRYE: I do not know; no one appears to have examined this question, you may 
be alluding to recent reports that prolactin has gonad inhibiting activity in the 
European newt (4). It would be of interest to know if prolactin plays any role in 
delaying gonad maturation of larvae until after metamorphosis. 
Nroonn: unfortunately, we did not measure trunk length in the tadpoles TThi& 
we treated with prolactin and growth hormone. We only measured the tail and 
body weight.. However, we are beginning to think that many of the reported 
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somatotropic effects of ovine pro&tin among the vertebrates may be only of 
academic interest and have no real physiological significance. Preparations of ovine 
prolactin are claimed to have somatotropic effects in animals ranging from teleosis 
to mammals, including man. In the latter species, ovine and bovine growth hor- 
mones are inactive. In sheep, ovine prolactin does not act like growth hormone. 
Another example of a target organ that fails to discriminate among prolactins and 
somatotropins is the mouse mammary gland, which shows a lactogenic response to 
ovine or bovine growth hormone. These examples illustrate that with heterologous 
hormones, the receptors for prolactin and growth, hormone are frequently poor dis- 
criminators. This serves to emphasize the importance of using homologous hormones 
for obtaining meaningful physiological information. 
GESCHWIND : In the hypophysectomized mammal, growth hormone synergizes 
with small amounts of thyroxine in producing growth. Does such a synergism occur 
in the hypophysectomized adult amphibian? 
F&YE: So far as I am aware there have been no studies of the role of the thyroid 
in the growth of post-metamorphic amphibians, so we do not know whether 
synergism between growth hormone and thyroxine occurs as in mammals. In larval 
amphibians the situation is complex. For example, thyroidectomy has been reported 
to increase growth of animals with intact pituitaries, whereas the growth of hy- 
pophysectomized tadpoles can be restored to normal by very small doses of thyroxin 
without any pituitary hormones present. 
HANKE: ACTH and corticosteroids are also involved in the induction of meta- 
morphic changes. One of my coworkers, Dr. Leist, could demonstrate that ACTH 
or corticosteroids support the metabolism on a metabolic basis. These hormones 
accelerate metamorphosis in accelerating metabolic changes which occur during 
development. 
